240 related articles for article (PubMed ID: 4110537)
1. General considerations in intermittent drug therapy of pulmonary tuberculosis.
Fox W
Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis treatment: dangerous regimens?
Rieder HL; Arnadottir T; Trébucq A; Enarson DA
Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
[No Abstract] [Full Text] [Related]
3. What about short course and intermittent chemotherapy for tuberculosis in children?
Smith MH
Pediatr Infect Dis; 1982; 1(5):298-303. PubMed ID: 6984178
[No Abstract] [Full Text] [Related]
4. [Drug therapy of tuberculosis].
Jentgens H
Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
[No Abstract] [Full Text] [Related]
5. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
Pilipchuk NS
Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
[No Abstract] [Full Text] [Related]
6. [Advances and principles in tuberculostatic therapy].
Bethge H
Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
[No Abstract] [Full Text] [Related]
7. [Chemotherapeutic studies on advanced tuberculosis in mice].
Grumbach F
Bibl Tuberc; 1965; 21():31-96. PubMed ID: 4301034
[No Abstract] [Full Text] [Related]
8. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
Utkin VV
Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901
[No Abstract] [Full Text] [Related]
9. Intermittent chemotherapy.
Tubercle; 1967 Mar; 48(1):58-61. PubMed ID: 4166513
[No Abstract] [Full Text] [Related]
10. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Pretet S; Grosset J; Perdrizet S
Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
Dickinson JM
Bull Int Union Tuberc; 1968 Dec; 41():309-15. PubMed ID: 4179554
[No Abstract] [Full Text] [Related]
12. Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials.
Tubercle; 1968 Sep; 49(3):281-90. PubMed ID: 4884773
[No Abstract] [Full Text] [Related]
13. [Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Virchow C
Munch Med Wochenschr; 1969 Aug; 111(35):1717-22. PubMed ID: 4309162
[No Abstract] [Full Text] [Related]
14. Clinical experience with ethambutol.
Wilson TM
Antibiot Chemother; 1970; 16():222-9. PubMed ID: 4108890
[No Abstract] [Full Text] [Related]
15. [Drug therapy of urogenital tuberculosis].
König K
Urologe; 1970 Jan; 9(1):44. PubMed ID: 5461516
[No Abstract] [Full Text] [Related]
16. Management of drug failure cases.
Dingley HB
Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():76-89. PubMed ID: 4145683
[No Abstract] [Full Text] [Related]
17. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
18. New trends in the chemotherapy of tuberculosis--current aspects.
Zierski M
Pneumonologie; 1974 Jun; 150(1):1-12. PubMed ID: 4135222
[No Abstract] [Full Text] [Related]
19. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
[No Abstract] [Full Text] [Related]
20. 180 doses in 26 weeks vs 56 doses in 24 weeks of chemotherapy in pulmonary tuberculosis: a preliminary report.
Jittinandana A; Kecharanandana P; Payanandana W; Daramas M
J Med Assoc Thai; 1988 May; 71(5):238-43. PubMed ID: 2456361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
